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Abstract
Background: Environmental factors, including infectious agents, are speculated to play a role in the rising
prevalence and the geographic distribution of celiac disease, an autoimmune disorder. In the USA and Sweden
where the regional variation in the frequency of celiac disease has been studied, a similarity with the geographic
distribution of Lyme disease, an emerging multisystemic infection caused by Borrelia burgdorferi spirochetes, has
been found, thus raising the possibility of a link. We aimed to determine if infection with Borrelia contributes to an
increased risk of celiac disease.
Methods: Biopsy reports from all of Sweden’s pathology departments were used to identify 15,769 individuals with
celiac disease. Through linkage to the nationwide Patient Register, we compared the rate of earlier occurrence of
Lyme disease in the patients with celiac disease to that in 78,331 matched controls. To further assess the temporal
relationship between Borrelia infection and celiac disease, we also examined the risk of subsequent Lyme disease in
patients with a diagnosis of celiac disease.
Results: Twenty-five individuals (0.16%) with celiac disease had a prior diagnosis of Lyme disease, whereas 79
(0.5%) had a subsequent diagnosis of Lyme disease. A modest association between Lyme disease and celiac disease
was seen both before (odds ratio, 1.61; 95% confidence interval (CI), 1.06–2.47) and after the diagnosis of celiac
disease (hazard ratio, 1.82; 95% CI, 1.40–2.35), with the risk of disease being highest in the first year of follow-up.
Conclusions: Only a minor fraction of the celiac disease patient population had a prior diagnosis of Lyme disease.
The similar association between Lyme disease and celiac disease both before and after the diagnosis of celiac
disease is strongly suggestive of surveillance bias as a likely contributor. Taken together, the data indicate that
Borrelia infection is not a substantive risk factor in the development of celiac disease.
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Background
Celiac disease is an autoimmune enteropathy with genetic,
environmental, and immunologic components [1]. It is
characterized by an aberrant immune response to ingested
wheat gluten and related proteins of rye and barley that
leads to inflammation and tissue damage in the small intestine [2]. Celiac disease is strongly associated with genes for
the specific class II human leukocyte antigens (HLAs) DQ2
and DQ8 [3]. It is estimated to affect close to 1% of the
American population [4, 5], compared with up to 2–3% in
Sweden and Finland [6, 7]. Because it can occur at any age,
factors other than genes and gluten ingestion are believed
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to play a significant role in disease onset. In addition, recent
studies point to an increasing prevalence of celiac disease
in the USA and Europe within the past few decades [8–10],
underscoring the potential contribution of environmental
factors. Among these, exposure to infectious agents, particularly those affecting the gastrointestinal tract, and the
risk of celiac disease have been examined in several studies
[11–14], but the results are not consistent, and a firm conclusion has not been reached [15, 16]. A recent study demonstrates that the inflammation caused by reovirus
infection can contribute to the development of autoimmunity in celiac disease through the suppression of peripheral regulatory T cell conversion [17].
Lyme disease, also known as Lyme borreliosis, is caused
by the Borrelia burgdorferi sensu lato spirochetal bacteria.
B. burgdorferi sensu stricto is the primary cause of Lyme
borreliosis in the USA, whereas B. afzelii, B. garinii, and B.
burgdorferi are the causative agents in Europe [18]. Lyme
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disease is currently the most common vector-borne infection in the USA and Europe, where its incidence has been
rapidly increasing in recent years [19, 20]. Although antibiotic therapy resolves clinical symptoms in the majority of
cases, a fraction of patients will develop persistent joint inflammation that does not respond to antibiotic treatment
[21]. The antibiotic-refractory Lyme arthritis is believed to
be the result of Borrelia infection-induced autoimmunity
and is associated with autoantibodies [22, 23], an acutephase inflammatory response [24], and the class II major
histocompatibility complex (MHC) molecule HLA-DR4
[25]. The condition often responds to immunomodulatory
or anti-inflammatory agents [26].
The potential for the contribution of infection with Borrelia to a later onset of celiac disease or gluten sensitivity
has recently garnered attention and is discussed in various
Internet forums [27–29]. In addition, recent studies from
the USA and Sweden examining the regional variation in
the frequency of celiac disease have demonstrated some
similarity with the geographic distribution of Lyme disease. In the USA, celiac disease has been found to be most
prevalent in the Northeast and the Midwest regions [30],
where the great majority of cases of B. burgdorferi infection also occur [19]. In Sweden, the highest incidence of
celiac disease has been associated with the southern region [31], where Lyme disease is endemic [32]. Despite
the similar pattern of geographic distribution and the publicized conjecture regarding a potential link between celiac
disease and Lyme borreliosis, studies to assess such an
association are lacking. In this study, we use a populationbased approach to examine whether infection with Borrelia increases the risk of celiac disease.

Methods
Study population

For this study, celiac disease was defined as a patient’s having villous atrophy (Marsh 3 histopathology grade) [33].
Earlier validation found that 96–100% of all gastroenterologists and pediatricians in Sweden performed a biopsy before
celiac disease diagnosis during the study period and that in
cases of reported villous atrophy, a comorbidity other than
celiac disease was rare [34]. Data on villous atrophy were
obtained from computerized biopsy reports from all of Sweden’s 28 pathology departments. Biopsies had been carried
out in 1969–2008, while the data collection took place in
2006–2008. Biopsy data included personal identity number,
date of biopsy, topography (duodenum and jejunum), and
morphology. The biopsy reports were on average based on
three tissue specimens [35], which would be expected to detect 95% of all celiac disease cases [36]. Biopsy was required
for celiac disease diagnosis throughout the study period. Biopsy data were linked through the unique personal identity
number [37] to inpatient and hospital-based outpatient data
with respect to a previous diagnosis of Lyme disease.
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Exposure to Borrelia infection was defined as having the
relevant International Classification of Diseases (ICD)
code for Lyme disease in the Swedish Patient Register
(ICD-10: A69.2) [38]. The registry began in 1964 and became nationwide in 1987. The Patient Register was limited
to inpatient data until 2000, but since 2001 it has also contained hospital-based outpatient data. The ICD code for
Lyme disease was introduced in 1997.
We matched each individual with celiac disease with up
to five controls for sex, age, county, and calendar year. Controls were selected by the Statistics Sweden government
agency, using the Swedish Total Population Register [39].
Since information regarding diagnosis of Lyme disease
was available starting on January 1, 1997, we only included
study participants on or after January 1, 1998 (i.e., so that
all participants had the potential to be exposed to a Lyme
disease diagnosis for at least one year). This resulted in
15,769 individuals with celiac disease and 78,331 matched
controls.
Statistical analysis

We used conditional logistic regression to calculate odds
ratios (ORs) for later celiac disease among individuals
with Lyme disease. The conditional approach means that
each individual with celiac disease was only compared
with his/her matched control (within a stratum). In this
way, age, sex, county, and calendar year do not affect
risk estimates. Furthermore, we examined the risk of celiac disease according to the time since the diagnosis of
Lyme disease (<1, 1–4.99, and ≥ 5 years). We also adjusted for country of birth (Nordic vs. not Nordic) and
educational level using four a priori-defined categories
[40]. Four percent of study participants lacked data on
educational level and were fitted into a separate fifth category in the multivariate analysis.
To assess the temporal relationship between celiac disease and Lyme disease, we also examined the risk of
later Lyme disease in patients with an initial diagnosis of
celiac disease. This analysis was restricted to 15,742 individuals without a prior Lyme disease diagnosis at first biopsy with celiac disease and 78,230 matched controls.
Cox regression was used to estimate the hazard ratio
(HR). The follow-up period continued for each celiac
disease patient and control until the first Lyme disease
diagnosis, death, emigration, or December 31, 2009.
We used SPSS 22 (SPSS, Inc.) for all analyses. The OR
and HR findings with 95% confidence intervals that did not
overlap with 1.0 were regarded as statistically significant.
Ethics

This study was approved by the Ethics Review Board of
Stockholm, Sweden. According to the board’s decision,
no study participant was contacted, and the study was
strictly register-based [41].
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Results
The demographic characteristics of the study participants are shown in Table 1. The median year of study
entry was 2002, and the median age at celiac disease
diagnosis (and corresponding age in matched controls)
was 32 years (range 0–95).
Twenty-five (0.16%) individuals with celiac disease and
73 (0.09%) controls had a record of earlier Lyme disease
(OR, 1.61; 95% CI, 1.06–2.47) (Table 1). Adjustment for
the level of education and Nordic origin did not substantially alter the risk (adjusted OR, 1.58; 95% CI, 1.03–2.41).
The OR was highest in the first year after Lyme disease
diagnosis (OR, 1.87; 95% CI, 0.87–4.00) but remained
positive between 1 and 5 years (OR, 1.48; 95% CI, 0.84–
2.60) and thereafter (OR, 1.72; 95% CI, 0.51–5.81). ORs
for celiac disease were similar in men (OR, 1.64; 95% CI,
0.81–3.32) and women (OR, 1.60; 95% CI, 0.94–2.72) (P
for interaction, 0.962).
In the prospective analysis, we found that 79 individuals with celiac disease (0.50%) and 215 controls (0.27%)
had a record of later Lyme disease (HR, 1.82; 95% CI,
1.40–2.35) (Table 1). Adjustment for the level of education and Nordic origin had no substantial effect (adjusted HR, 1.82; 95% CI, 1.40–2.37). The risk of Lyme
disease was highest in the first year of follow-up (HR,
2.18; 95% CI, 1.07–4.44) but remained significantly increased between 1 and 5 years after celiac disease diagnosis (HR, 1.97; 95% CI, 1.41–2.77), and positive
thereafter (HR, 1.44; 95% CI, 0.88–2.34). HRs for Lyme
disease were not significantly different in men (HR, 2.39;
95% CI, 1.71–3.56) and women (HR, 1.51; 95% CI, 1.08–

2.133) (P for interaction, 0.134). The relative risk in the
prospective analysis was not significantly different from
that in the main analysis.

Discussion
The strengths of this study are its nationwide populationbased design and high statistical power. The prevalence of
celiac disease in Sweden is among the highest in the world
[6], making the setting of this study particularly relevant.
Furthermore, the majority of the Swedish population lives
in areas where Lyme disease is endemic [32]. Because
Lyme borreliosis is not a notifiable infection in Europe, accurate estimates of its current incidence in Sweden are
not available. However, a recent study found a mean annual incidence of 464 cases of erythema migrans (a skin
lesion indicative of the early stage of Lyme disease) per
100,000 inhabitants in southeastern Sweden between 1997
and 2002, with a sharp increase in the rate being observed
during the analyzed period [20]. In neighboring Norway, a
recent study of anti-B. burgdorferi IgG seroprevalence (indicative of possible ongoing or past episode of Lyme disease) reported a rate of about 4% [42].
Infectious agents have been linked to the pathogenesis of
a number of autoimmune diseases, with one or more
mechanisms, such as molecular mimicry, epitope spreading, bystander activation, and suppression of regulatory T
cell function, being implicated [43, 44]. In this study, we
found a modest association between celiac disease and a
prior record of Lyme borreliosis. However, we also found
celiac disease to be similarly associated with a subsequent
occurrence of the infection. Furthermore, both associations

Table 1 Characteristics of patients with celiac disease and matched controls
Characteristic

Main analysisa
Matched controls

No. of participants

78,331

Prospective analysisb
Celiac disease
15,769

Matched controls
b

78,230

Celiac disease
15,742b

Sex
Male, no. (%)

28,934 (36.9)

5837 (37.0)

28,890 (36.9)

5826 (37.0)

Female, no. (%)

49,397 (63.1)

9932 (63.0)

49,340 (63.1)

9916 (63.0)

≤ 19 years, no. (%)

29,510 (37.7)

5917 (37.5)

29,455 (37.7)

5900 (37.5)

20–39 years, no. (%)

15,746 (20.1)

3167 (20.1)

15,738 (20.1)

3167 (20.1)

40–59 years, no. (%)

17,245 (22.0)

3464 (22.0)

17,226 (22.0)

3460 (22.0)

≥ 60 years, no. (%)

15,830 (20.2)

3221 (20.4)

15,811 (20.2)

3215 (20.4)

1998–2002, no. (%)

39,492 (50.4)

7956 (50.5)

39,476 (50.5)

7952 (50.5)

2003–2008, no. (%)

38,839 (49.6)

7813 (49.5)

38,754 (49.5)

7790 (49.5)

73 (0.09)

25 (0.16)

215 (0.27)

79 (0.50)

Agec

Calendar periodc

Lyme disease, no. (%)
a

To assess the risk of celiac disease following a diagnosis of Lyme disease
b
To assess the risk of later Lyme disease in patients with a diagnosis of celiac disease. We excluded patients with an earlier diagnosis of Lyme disease. In addition,
two celiac disease patients with potential data irregularity were excluded
c
At the time of celiac disease diagnosis
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were strongest in the first year after diagnosis. As such, the
observed modest association between celiac disease and
Lyme disease is almost certainly due to surveillance bias,
driven by the possibility that physicians would be more
likely to investigate a patient presenting with Borrelia infection for markers of celiac disease (and vice versa). Given
that there is some overlap between the systemic symptoms
of Lyme disease and celiac disease, it is reasonable to assume that such surveillance bias would have increased the
probability of celiac disease diagnosis in this study.
We acknowledge that patients with celiac disease may be
different from controls in a number of ways that have not
been measured. Though our cases were matched to controls by age, sex, county, and calendar year, there could be
differences between cases and controls in relationship to
both celiac disease and Lyme borreliosis which may contribute to the observed results. Therefore, while strongly
suggestive of surveillance bias as the likely source for the
association, other components, such as shared genetic, environmental, or other factors between celiac disease and
Lyme disease might be potential additional contributors.
For example, a variable previously found to be associated
with Lyme borreliosis and celiac disease is income [45, 46].
Furthermore, it is important to note that the results and
conclusions of this study cannot be extrapolated to forms
of gluten sensitivity other than celiac disease.

Conclusions
In summary, we found that, despite the high rates of occurrence of both celiac disease and Lyme disease in the
population for this study, only a minor fraction of the
celiac disease patients had an earlier record of Lyme disease. Furthermore, the modest relationship between
Lyme disease and celiac disease both before and after
the diagnosis of celiac disease points to surveillance bias
or shared risk factors as the likely contributors. Taken
together, our data argue against a causal association of
Borrelia infection with celiac disease.
Abbreviations
B. afzelii: Borrelia afzelii; B. burgdorferi: Borrelia burgdorferi; B. garinii: Borrelia
garinii; CI: confidence interval; HLA: human leukocyte antigen; HR: hazard ratio;
ICD: International Classification of Diseases; MHC: major histocompatibility
complex; OR: odds ratio

Funding
AA was supported by grants from the National Institute of Allergy and
Infectious Diseases of the National Institutes of Health (R56AI093763) and the
Global Lyme Alliance. JFL was supported by grants from the Swedish Society
of Medicine, the Swedish Research Council — Medicine (522-2A09-195), the
Swedish Celiac Society, and the Fulbright Commission.

Availability of data and materials
The datasets used and/or analyzed during the current study are available
from the corresponding author on reasonable request.

Page 4 of 5

Role of the sponsors
None of the funders had any role in the design or conduct of the study;
collection, management, analysis, or interpretation of the data; or
preparation, review, or approval of the manuscript.
Authors’ contributions
AA, BL, and JFL conceived the study; JFL completed the study design, data
acquisition, and statistical analysis; AA, BL, GPW, PHG, and JFL contributed to
the study design and interpretation of data; AA and JFL drafted the
manuscript; BL, GPW, and PHG reviewed and contributed to the revision of
the manuscript for important intellectual content; JFL had full access to all of
the data in the study and takes responsibility for the integrity of the data
and the accuracy of the data analysis. All authors read and approved the
final manuscript.
Ethics approval and consent to participate
This project (2008/1182-31/4) was approved by the Research Ethics
Committee of the Karolinska Institute, Sweden on September 3, 2008.
Consent for publication
Not applicable.
Competing interests
GPW reports receiving research grants from Immunetics, Inc., Institute for
Systems Biology, Rarecyte, Inc., and bioMérieux SA. He owns equity in
Abbott, has been an expert witness in malpractice cases involving Lyme
disease, and is an unpaid board member of the American Lyme Disease
Foundation.

Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1
Department of Medicine, Columbia University Medical Center, New York,
NY, USA. 2Celiac Disease Center, Columbia University Medical Center, New
York, NY, USA. 3Institute of Human Nutrition, Columbia University Medical
Center, New York, NY, USA. 4Department of Medical Epidemiology and
Biostatistics, Karolinska Institutet, Stockholm, Sweden. 5Division of Infectious
Diseases, Department of Medicine, New York Medical College, Valhalla, NY,
USA. 6Department of Pediatrics, Örebro University Hospital, Örebro, Sweden.
7
Division of Epidemiology and Public Health, School of Medicine, University
of Nottingham, Nottingham, UK.
Received: 28 April 2017 Accepted: 9 August 2017

References
1. Green PH, Lebwohl B, Greywoode R. Celiac disease. J Allergy Clin Immunol.
2015;135:1099–106.
2. Guandalini S, Assiri A. Celiac disease: a review. JAMA Pediatr. 2014;168:272–8.
3. Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex
genetics of a complex disorder. Tissue Antigens. 2003;61:105–17.
4. Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The
prevalence of celiac disease in the United States. Am J Gastroenterol. 2012;
107:1538–44. quiz 7, 45.
5. Katz KD, Rashtak S, Lahr BD, et al. Screening for celiac disease in a North
American population: sequential serology and gastrointestinal symptoms.
Am J Gastroenterol. 2011;106:1333–9.
6. Myleus A, Ivarsson A, Webb C, et al. Celiac disease revealed in 3% of Swedish
12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr. 2009;49:
170–6.
7. Vilppula A, Collin P, Maki M, et al. Undetected coeliac disease in the elderly:
a biopsy-proven population-based study. Dig Liver Dis. 2008;40:809–13.
8. Catassi C, Kryszak D, Bhatti B, et al. Natural history of celiac disease
autoimmunity in a USA cohort followed since 1974. Ann Med. 2010;42:530–8.
9. Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac
disease over time. Aliment Pharmacol Ther. 2007;26:1217–25.
10. Riddle MS, Murray JA, Porter CK. The incidence and risk of celiac disease in
a healthy US adult population. Am J Gastroenterol. 2012;107:1248–55.

Alaedini et al. BMC Medicine (2017) 15:169

11. Welander A, Tjernberg AR, Montgomery SM, Ludvigsson J, Ludvigsson JF.
Infectious disease and risk of later celiac disease in childhood. Pediatrics.
2010;125:e530–6.
12. Stene LC, Honeyman MC, Hoffenberg EJ, et al. Rotavirus infection frequency
and risk of celiac disease autoimmunity in early childhood: a longitudinal
study. Am J Gastroenterol. 2006;101:2333–40.
13. Myleus A, Hernell O, Gothefors L, et al. Early infections are associated with
increased risk for celiac disease: an incident case-referent study. BMC
Pediatr. 2012;12:194.
14. Marild K, Kahrs CR, Tapia G, Stene LC, Stordal K. Infections and risk of celiac
disease in childhood: a prospective nationwide cohort study. Am J
Gastroenterol. 2015;110:1475–84.
15. Lebwohl B, Ludvigsson JF, Green PH. Celiac disease and non-celiac gluten
sensitivity. BMJ. 2015;351:h4347.
16. Plot L, Amital H. Infectious associations of Celiac disease. Autoimmun Rev.
2009;8:316–9.
17. Bouziat R, Hinterleitner R, Brown JJ, et al. Reovirus infection triggers
inflammatory responses to dietary antigens and development of celiac
disease. Science. 2017;356:44–50.
18. Steere AC, Strle F, Wormser GP, et al. Lyme borreliosis. Nat Rev Dis Primers.
2016;2:16090.
19. Lyme disease: data and statistics. http://www.cdc.gov/lyme/stats/index.html.
Accessed 13 Apr 2017.
20. Bennet L, Halling A, Berglund J. Increased incidence of Lyme borreliosis in
southern Sweden following mild winters and during warm, humid summers.
Eur J Clin Microbiol Infect Dis. 2006;25:426–32.
21. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment,
treatment, and prevention of Lyme disease, human granulocytic
anaplasmosis, and babesiosis: clinical practice guidelines by the
Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089–134.
22. Pianta A, Drouin EE, Crowley JT, et al. Annexin A2 is a target of autoimmune T
and B cell responses associated with synovial fibroblast proliferation in patients
with antibiotic-refractory Lyme arthritis. Clin Immunol. 2015;160:336–41.
23. Crowley JT, Drouin EE, Pianta A, et al. A highly expressed human protein,
apolipoprotein B-100, serves as an autoantigen in a subgroup of patients
with Lyme disease. J Infect Dis. 2015;212:1841–50.
24. Uhde M, Ajamian M, Li X, Wormser GP, Marques A, Alaedini A. Expression of
C-reactive protein and aerum amyloid A in early to late manifestations of
Lyme disease. Clin Infect Dis. 2016;163:1399–404.
25. Steere AC, Dwyer E, Winchester R. Association of chronic Lyme arthritis with
HLA-DR4 and HLA-DR2 alleles. N Engl J Med. 1990;323:219–23.
26. Arvikar SL, Steere AC. Diagnosis and treatment of Lyme arthritis. Infect Dis
Clin North Am. 2015;29:269–80.
27. Undiagnosed Lyme disease possible connection to celiac disease. http://
ellensceliacinformation.blogspot.com/2011/12/lyme-disease-possibleconnection-to.html. Accessed 18 Aug 2017.
28. What does gluten have to do with Lyme? http://lymemd.blogspot.com/2008/
05/what-does-gluten-have-to-do-with-lyme.html. Accessed 18 Aug 2017.
29. Conditions associated with celiac disease. http://www.bidmc.org/Centersand-Departments/Departments/Digestive-Disease-Center/Services/CeliacCenter/FAQ/Conditions-Associated-with-Celiac-Disease.aspx. Accessed 18
Aug 2017.
30. Unalp-Arida A, Ruhl CE, Choung RS, Brantner TL, Murray JA. Lower
prevalence of celiac disease and gluten-related disorders in persons living
in southern vs northern Latitudes of the United States. Gastroenterology.
2017;152:1922–32.e2.
31. Namatovu F, Lindkvist M, Olsson C, Ivarsson A, Sandstrom O. Season and
region of birth as risk factors for coeliac disease a key to the aetiology?
Arch Dis Child. 2016;101:1114–8.
32. Berglund J, Eitrem R, Ornstein K, et al. An epidemiologic study of Lyme
disease in southern Sweden. N Engl J Med. 1995;333:1319–27.
33. Marsh MN. Gluten, major histocompatibility complex, and the small
intestine. A molecular and immunobiologic approach to the spectrum of
gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102:330–54.
34. Ludvigsson JF, Brandt L, Montgomery SM, Granath F, Ekbom A. Validation
study of villous atrophy and small intestinal inflammation in Swedish biopsy
registers. BMC Gastroenterol. 2009;9:19.
35. Ludvigsson JF, Brandt L, Montgomery SM. Symptoms and signs in
individuals with serology positive for celiac disease but normal mucosa.
BMC Gastroenterol. 2009;9:57.

Page 5 of 5

36. Pais WP, Duerksen DR, Pettigrew NM, Bernstein CN. How many duodenal
biopsy specimens are required to make a diagnosis of celiac disease?
Gastrointest Endosc. 2008;67:1082–7.
37. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish
personal identity number: possibilities and pitfalls in healthcare and medical
research. Eur J Epidemiol. 2009;24:659–67.
38. Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation
of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
39. Ludvigsson JF, Almqvist C, Bonamy AE, et al. Registers of the Swedish
total population and their use in medical research. Eur J Epidemiol.
2016;31:125–36.
40. Olen O, Bihagen E, Rasmussen F, Ludvigsson JF. Socioeconomic position
and education in patients with coeliac disease. Dig Liver Dis. 2012;44:471–6.
41. Ludvigsson JF, Haberg SE, Knudsen GP, et al. Ethical aspects of registrybased research in the Nordic countries. Clin Epidemiol. 2015;7:491–508.
42. Vestrheim DF, White RA, Aaberge IS, Aase A. Geographical differences in
seroprevalence of Borrelia burgdorferi antibodies in Norway, 2011-2013. Ticks
Tick Borne Dis. 2016;7:698–702.
43. Ercolini AM, Miller SD. The role of infections in autoimmune disease. Clin
Exp Immunol. 2009;155:1–15.
44. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune
tolerance. Cell. 2008;133:775–87.
45. Seukep SE, Kolivras KN, Hong Y, et al. An examination of the demographic
and environmental variables correlated with Lyme disease emergence in
Virginia. Ecohealth. 2015;12:634–44.
46. Namatovu F, Stromgren M, Ivarsson A, et al. Neighborhood conditions and
celiac disease risk among children in Sweden. Scand J Public Health. 2014;
42:572–80.

Submit your next manuscript to BioMed Central
and we will help you at every step:
• We accept pre-submission inquiries
• Our selector tool helps you to find the most relevant journal
• We provide round the clock customer support
• Convenient online submission
• Thorough peer review
• Inclusion in PubMed and all major indexing services
• Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit

